Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LifeMD, Inc. Director's Dealing 2020

Dec 1, 2020

33298_dirs_2020-12-01_cd4d724f-71bf-4c9c-95a1-0f8fd5c6a550.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2020-11-27

Reporting Person: Alvarez Nicholas P (Chief Acquisition Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-27 Common Stock, par value $0.001 M 105288 $1.15 Acquired 109288 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-11-27 Options to purchase Common Stock $1.15 M 105288 Disposed Common Stock, par value $0.001 (105288) Direct

Footnotes

F1: Represents a cashless exercise of outstanding stock options to purchase 120,000 shares of common stock. Mr. Alvarez received 105,288 shares of common stock and surrendered 14,712 shares of common stock underlying the option in payment of the exercise price. The Options were issued to Mr. Alvarez pursuant to the terms of an employment agreement, dated July 26, 2018, by and between Mr. Alvarez and the Issuer.